Sustained clinical and structural benefit after joint distraction in the treatment of severe knee osteoarthritis

Osteoarthritis and Cartilage

Volumn 21, Issue 11, 2013, Pages 1660-1667

  Wiegant, K ^a,b   Van Roermund, P M ^b   Intema, F ^a   Cotofana, S ^b   Eckstein, F ^b   Mastbergen, S C ^a   Lafeber, F P J G ^a  

^a UMCU   (Netherlands)

^b PMU ^*  (Austria)

Author keywords

Cartilage repair; Joint distraction; Knee; MRI; Osteoarthritis; Treatment

Indexed keywords

ACENOCOUMAROL; COLLAGEN TYPE 2; FLUCLOXACILLIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DEVICE INFECTION; DISTRACTION OSTEOGENESIS; EXTERNAL FIXATOR; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; KNEE OSTEOARTHRITIS; LUNG EMBOLISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PARAMETERS; PRIORITY JOURNAL; TOTAL KNEE REPLACEMENT; TURNOVER TIME; VENOUS THROMBOEMBOLISM; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; ARTICULAR CARTILAGE; EVALUATION STUDY; KNEE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATHOLOGY; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; CARTILAGE, ARTICULAR; COLLAGEN TYPE II; EXTERNAL FIXATORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OSTEOGENESIS, DISTRACTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84884983950     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.08.006     Document Type: Article

References (37)

1. Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011, 377:2115-2126.
2. Kinds M.B., Welsing P.M., Vignon E.P., Bijlsma J.W., Viergever M.A., Marijnissen A.C., et al. Asystematic review of the association between radiographic and clinical osteoarthritis of hip and knee. Osteoarthritis Cartilage 2011, 19:768-778.
3. Neogi T., Felson D., Niu J., Nevitt M., Lewis C.E., Aliabadi P., et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 2009, 339:b2844.
4. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
5. Iorio R., Robb W.J., Healy W.L., Berry D.J., Hozack W.J., Kyle R.F., et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. JBone Joint Surg Am 2008, 90:1598-1605.
6. Mastbergen S.C., Saris D.B., Lafeber F. Functional articular cartilage repair: here, near, or is the best approach not yet clear?. Nat Rev Rheumatol 2013, 9:277-290.
7. Hunter D.J., Lo G.H. The management of osteoarthritis: an overview and call to appropriate conservative treatment. Med Clin North Am 2009, 93:127-143. xi.
8. Zweers M.C., de Boer T.N., van Roon J., Bijlsma J.W., Lafeber F.P., Mastbergen S.C. Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Res Ther 2011, 13:239.
9. Conaghan P.G., Dickson J., Grant R.L. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ 2008, 336:502-503.
10. Lutzner J., Kasten P., Gunther K.P., Kirschner S. Surgical options for patients with osteoarthritis of the knee. Nat Rev Rheumatol 2009, 5:309-316.
11. Kurtz S.M., Lau E., Ong K., Zhao K., Kelly M., Bozic K.J. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res 2009, 467:2606-2612.
12. Bitton R. The economic burden of osteoarthritis. Am J Manag Care 2009, 15:S230-S235.
13. Losina E., Walensky R.P., Kessler C.L., Emrani P.S., Reichmann W.M., Wright E.A., et al. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med 2009, 169:1113-1121. discussion 1121-1112.
14. Intema F., Thomas T.P., Anderson D.D., Elkins J.M., Brown T.D., Amendola A., et al. Subchondral bone remodeling is related to clinical improvement after joint distraction in the treatment of ankle osteoarthritis. Osteoarthritis Cartilage 2011, 19:668-675.
15. Marijnissen A.C., van Roermund P.M., van Melkebeek J., Lafeber F.P. Clinical benefit of joint distraction in the treatment of ankle osteoarthritis. Foot Ankle Clin 2003, 8:335-346.
16. Ploegmakers J.J., van Roermund P.M., van Melkebeek J., Lammens J., Bijlsma J.W., Lafeber F.P., et al. Prolonged clinical benefit from joint distraction in the treatment of ankle osteoarthritis. Osteoarthritis Cartilage 2005, 13:582-588.
17. Aldegheri R., Trivella G., Saleh M. Articulated distraction of the hip. Conservative surgery for arthritis in young patients. Clin Orthop Relat Res 1994, 94-101.
18. Deie M., Ochi M., Adachi N., Kajiwara R., Kanaya A. Anew articulated distraction arthroplasty device for treatment of the osteoarthritic knee joint: a preliminary report. Arthroscopy 2007, 23:833-838.
19. Wiegant K., van Heerwaarden R.J., van Roermund P.M., Mastbergen S.C. Intrinsic joint tissue repair by joint distraction. OA Arthritis 2013; Feb 02, 1-4.
20. Intema F., Van Roermund P.M., Marijnissen A.C., Cotofana S., Eckstein F., Castelein R.M., et al. Tissue structure modification in knee osteoarthritis by use of joint distraction: an open 1-year pilot study. Ann Rheum Dis 2011, 70:1441-1446.
21. Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L.W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. JRheumatol 1988, 15:1833-1840.
22. Marijnissen A.C., Vincken K.L., Vos P.A., Saris D.B., Viergever M.A., Bijlsma J.W., et al. Knee Images Digital Analysis (KIDA): a novel method to quantify individual radiographic features of knee osteoarthritis in detail. Osteoarthritis Cartilage 2008, 16:234-243.
23. Eckstein F., Ateshian G., Burgkart R., Burstein D., Cicuttini F., Dardzinski B., et al. Proposal for a nomenclature for magnetic resonance imaging based measures of articular cartilage in osteoarthritis. Osteoarthritis Cartilage 2006, 14:974-983.
24. Pham T., van der Heijde D., Altman R.D., Anderson J.J., Bellamy N., Hochberg M., et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004, 12:389-399.
25. Escobar A., Gonzalez M., Quintana J.M., Vrotsou K., Bilbao A., Herrera-Espineira C., et al. Patient acceptable symptom state and OMERACT-OARSI set of responder criteria in joint replacement. Identification of cut-off values. Osteoarthritis Cartilage 2012, 20:87-92.
26. Buck R.J., Wyman B.T., Le Graverand M.P., Wirth W., Eckstein F. An efficient subset of morphological measures for articular cartilage in the healthy and diseased human knee. Magn Reson Med 2010, 63:680-690.
27. Burgkart R., Glaser C., Hyhlik-Durr A., Englmeier K.H., Reiser M., Eckstein F. Magnetic resonance imaging-based assessment of cartilage loss in severe osteoarthritis: accuracy, precision, and diagnostic value. Arthritis Rheum 2001, 44:2072-2077.
28. Graichen H., von Eisenhart-Rothe R., Vogl T., Englmeier K.H., Eckstein F. Quantitative assessment of cartilage status in osteoarthritis by quantitative magnetic resonance imaging: technical validation for use in analysis of cartilage volume and further morphologic parameters. Arthritis Rheum 2004, 50:811-816.
29. Eckstein F., Buck R.J., Burstein D., Charles H.C., Crim J., Hudelmaier M., et al. Precision of 3.0Tesla quantitative magnetic resonance imaging of cartilage morphology in a multicentre clinical trial. Ann Rheum Dis 2008, 67:1683-1688.
30. Lethaby A., Temple J., Santy J. Pin site care for preventing infections associated with external bone fixators and pins. Cochrane Database Syst Rev 2008, CD004551.
31. Jones E.A., English A., Henshaw K., Kinsey S.E., Markham A.F., Emery P., et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004, 50:817-827.
32. Jones E.A., Crawford A., English A., Henshaw K., Mundy J., Corscadden D., et al. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum 2008, 58:1731-1740.
33. van Valburg A.A., van Roermund P.M., Lammens J., van Melkebeek J., Verbout A.J., Lafeber E.P., et al. Can Ilizarov joint distraction delay the need for an arthrodesis of the ankle? A preliminary report. JBone Joint Surg Br 1995, 77:720-725.
34. Grad S., Eglin D., Alini M., Stoddart M.J. Physical stimulation of chondrogenic cells invitro: a review. Clin Orthop Relat Res 2011, 469:2764-2772.
35. van Spil W.E., DeGroot J., Lems W.F., Oostveen J.C., Lafeber F.P. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 2010, 18:605-612.
36. Lo G.H., McAlindon T.E., Niu J., Zhang Y., Beals C., Dabrowski C., et al. Bone marrow lesions and joint effusion are strongly and independently associated with weight-bearing pain in knee osteoarthritis: data from the osteoarthritis initiative. Osteoarthritis Cartilage 2009, 17:1562-1569.
37. Moisio K., Eckstein F., Chmiel J.S., Guermazi A., Prasad P., Almagor O., et al. Denuded subchondral bone and knee pain in persons with knee osteoarthritis. Arthritis Rheum 2009, 60:3703-3710.